"Aside from being safe and also getting vaccinated, the kids can also enjoy the outdoors, the scenery, and the animals that are here inside," said Joyce Pablo, mother of one of the children being inoculated.
The new US study will include up to 1,420 volunteers ages 18 to 55 to test the updated Omicron-based shots for use as a booster or for primary vaccinations. Researchers will examine the tweaked vaccine’s safety and how it revs up the immune system...
The centre will specialise in providing COVID-19 vaccinations for children aged 3 to 16 years, in cooperation with the Ministry of Health and Prevention, the Department of Health in Abu Dhabi and the Abu Dhabi Early Childhood Authority.
The European Medicines Agency's human medicines committee "has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years of age."
"At a time where the Omicron variant is rapidly spreading, and where we need to step up vaccination and the administration of boosters, I am particularly pleased with today's authorisation of the Novavax vaccine," said EU chief Ursula von der Leyen.
Hundreds of people queue outside St Thomas hospital in London to get their third dose of the COVID-19 vaccine, as the UK ramps up its rollout to ensure all adults can receive a booster by the end of December.
The National Command and Operation Centre has allowed booster shots for people aged over 30 years because of the spread of the Omicron variant to over 100 countries, including Pakistan.
“Vaccinating older people is one of the most important and impactful ways to save lives during a pandemic. We know that senior citizens are at high risk for developing severe disease, getting hospitalised and dying from COVID-19,” Yadav told a public briefing.
After Omicron was detected in Pakistan, it also lowered the age limit for the administration of COVID-19 booster jabs from Jan.1 — individuals aged 30 years and above are eligible for it.
The new training hub comes after the UN agency set up a technology transfer hub in Cape Town, South Africa, last year to give companies from poor and middle-income countries the know-how to produce COVID-19 vaccines based on mRNA technology.